Obesity-associated cardiometabolic complications in polycystic ovary syndrome: The potential role of sodium-glucose cotransporter-2 inhibitors

Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder in reproductive-age women. PCOS is characterized by androgen excess, oligo/anovulation, and polycystic appearance of the ovaries. Women with PCOS have an increased prevalence of multiple cardiovascular risk factors such as insuli...

Descripción completa

Detalles Bibliográficos
Autores principales: Pruett, Jacob E., Romero, Damian G., Yanes Cardozo, Licy L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974663/
https://www.ncbi.nlm.nih.gov/pubmed/36875461
http://dx.doi.org/10.3389/fendo.2023.951099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974663/
https://www.ncbi.nlm.nih.gov/pubmed/36875461
http://dx.doi.org/10.3389/fendo.2023.951099

Ejemplares similares